INBX Inhibrx Biosciences, Inc.: institutional ownership and insider trading
176 funds reported holding $1.45B of Inhibrx Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $153M, with 48 new positions and 19 funds selling out; over the last 12 months insiders bought $6.35M and sold $279K on the open market.
Famous investors holding INBX
- Andreas Halvorsen (Viking Global Investors): $106M, 0.3% of the portfolio
- Izzy Englander (Millennium Management): $13.9M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $5.89M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $4.27M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $4.05M, 0.0% of the portfolio
Largest institutional holders of INBX
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $124M
- PERCEPTIVE ADVISORS LLC — $123M
- Sanofi (SNY, SNYNF) — $110M
- VIKING GLOBAL INVESTORS LP — $106M
- HighTower Advisors, LLC — $82.5M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $79.7M
- BlackRock, Inc. (BLK) — $78.3M
- Schonfeld Strategic Advisors LLC — $66.1M
- STATE STREET CORP (STT, STT-PG) — $60.7M
- VANGUARD GROUP INC — $49.2M
Recent INBX insider trades
- Oct 14, 2026: Lappe Mark bought 10,040 shares ($849K)
- Sep 28, 2026: Lappe Mark bought 10,000 shares ($999K)
- Sep 23, 2026: Kayyem Jon Faiz bought 5,000 shares ($500K)
- Sep 16, 2026: Kayyem Jon Faiz bought 5,000 shares ($500K)
5%+ owners
- Perceptive Advisors LLC: 10.0% (Schedule 13G/A, filed Aug 14, 2026)
- VIKING GLOBAL INVESTORS LP: 9.3% (Schedule 13G/A, filed Aug 14, 2026)
- BANK OF AMERICA CORP /DE/: 5.9% (Schedule 13G, filed Aug 3, 2026)
- Schonfeld Strategic Advisors LLC: 5.3% (Schedule 13G, filed Aug 14, 2026)